29Indexed trials
mesh condition
Lewy Body Disease
Intelligence
Lewy Body Disease intelligence: 29 indexed trials, 10 recruiting studies, 27 sponsors across 13 countries.
10Recruiting
27Sponsors
13Countries
Leading sponsors
Skane University Hospital33 recruiting
California Pacific Medical Center Research Institute10 recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau10 recruiting
Danish Dementia Research Centre10 recruiting
Eli Lilly and Company11 recruiting
Exonhit10 recruiting
Centre Hospitalier Universitaire, Amiens10 recruiting
Georgetown University10 recruiting
IRCCS San Raffaele10 recruiting
Johns Hopkins University10 recruiting
MD Stem Cells11 recruiting
Bastyr University11 recruiting
Geographic activity
United States17trials
Sweden3trials
Denmark2trials
France2trials
Belgium1trials
Spain1trials
Taiwan1trials
United Arab Emirates1trials
United Kingdom1trials
South Korea1trials
Canada1trials
Italy1trials
Leading interventions
Plasma Ab42/Ab402trials
Plasma neurofilament light (NfL)2trials
Behavioral : clinical, functional, cognitive and psychiatric evaluations1trials
Blood sampling1trials
Computerized tests and Electrophysiological measurements1trials
Different cognitive tests1trials
Donepezil1trials
Donanemab1trials
Elecsys (Roche) Abeta42, Ttau and Ptau1trials
Electroencephalogram1trials
Flutemetamol F18 Injection1trials
Biological : blood sampling1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.